Other Search Results
Jay S. Duker, M.D. - EyePoint Pharmaceuticals

President & CEO and Board Director ; Jay S. Duker, MD, is the President & CEO and Board Director of EyePoint Pharmaceuticals, a biopharmaceutical company that develops sustained-release medications to treat serious ocular disorders. Dr. Duker has devoted more than 30 years to the field of ophthalmology focused on improving eyesight and preventing blindness, holding roles in clinical research, business, and academic settings. Dr. Duker joined EyePoint in 2020. Prior to becoming President & CEO in...

Board of Directors | EyePoint Pharmaceuticals

Jay S. Duker, M.D. President & CEO and Board Director ; Göran Ando, M.D. Non Executive Chairman ; Nancy Lurker · Vice Chair, Board of Directors

Management | EyePoint Pharmaceuticals

Jay S. Duker, M.D. President & CEO and Board Director ; George O. Elston · Executive Vice President, Chief Financial Officer ; Ron Honig Esq. Chief Legal Officer & Company Secretary

Massachusetts Medical Society: MMS Leadership Biographies

Also, as a founding member and co-owner of Surgisite Boston, Dr. Liao is a member of its Quality Assurance Committee. At Emerson Hospital since 1996, she has held numerous committee...

2001 Corporate Allocation Percentage Report - Welcome to \,City of New York

2001 Corporate Allocation Percentage Report 1 A L SHET METAL FABRICATIONS 64.94 A PRODUCTTS INC 68.29 A R SECURITIES CORP 62.67 A OTTANO PROJECT CORP 60.84 A + SOFTWARE DEVELOPMENT INC 50....

CITY OF NEW YORK DEPARTMENT OF FINANCE 1998 - STOCK ALLOCATION BELOW 100 PERCENT REPORT

CITY OF NEW YORK DEPARTMENT OF FINANCE 1998 - STOCK ALLOCATION BELOW 100 PERCENT REPORT NAME ISSUERS ALLOCATION PERCENT NAME ISSUERS ALLOCATION PERCENT #78 GIAC LEASING CORPORATION 1.33 "K...

Copyright © www.babybloodtype.com. All rights reserved.
policy sang_list